Thomas M Zollner on OCEANIC-STROKE Study: Amazingly Good News for Patients With Stroke
Thomas M Zollner, Reproductive Health Cluster Lead at Bayer, reposted from Alexander Krupp on LinkedIn:
”Amazingly good news for patients with stroke: The Phase III study OCEANIC-STROKE in secondary stroke prevention met its primary endpoint.
Asundexian 50 mg once daily significantly reduced the risk of ischemic stroke compared to placebo, both in combination with antiplatelet therapy, in patients after a non-cardioembolic ischemic stroke or high-risk ischemic attack.
OCEANIC-STROKE is the first successfully completed Phase III study of a FactorXIa Inhibitor.
Each year, approximately 12 million people worldwide will experience a stroke.
Of these, 20-30% will be a recurrent stroke.
Despite available secondary stroke prevention options, the risk of secondary stroke remains high.
One in five stroke survivors will have another stroke within five years.”
Quoting Alexander Krupp‘s post:
”A new medicine was born today: We are just announcing positive results of the OCEANIC STROKE study in secondary stroke prevention.
There a few moments in a worklife when you can be part of a novel medicine being born.
For me, this is today: We are bringing a novel treatment option to millions of patients to reduce the risk of secondary ischemic stroke.
I am humble and honored to be part of such an incredible TeamBayer that has just made the impossible possible, unlocking superpowers in a new operating model DSO.
Thank you!”
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 11:36Ifeanyichukwu Ifechidere: From Running Tests to Trusting Interpretation in Coagulation
-
Apr 12, 2026, 11:30Zack Rosanova: What Happens to Your Brain Without Sleep
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine